TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2023 Earnings Conference Call May 1, 2023 8:30 AM ET
Company Participants
Mike Weiss - Chairman & CEO
Adam Waldman - CCO
Sean Power - CFO
Jenna Bosco - IR
Conference Call Participants
Eric Joseph - JPMorgan
Ed White - H. C. Wainwright
Prakhar Agrawal - Cantor Fitzgerald
Matt Kaplan - Ladenburg Thalmann
Mayank Mamtani - B. Riley Securities
Josh Schimmer - Evercore ISI
Operator
Greetings, and welcome to the TG Therapeutics First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It would now like to turn the call over to Jenna Bosco. Thank you. You may begin.
Jenna Bosco
Thank you. Welcome, everyone, and thanks for joining us this morning. I’m Jenna Bosco, and with me today to discuss the first quarter 2023 financial results and provide a business update are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer. Following our Safe Harbor statement, Mike will provide an overview of our recent corporate developments. Adam will provide an update on our commercialization efforts, and Sean will provide a brief overview of our financial results, before turning the call over to the operator to begin the Q&A session.
Before we begin, I’d like to remind everyone that we will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements about our anticipated future operating and financial performance, including sales performance, projected regulatory milestones, and expectations for our marketed and pipeline products. TG cautions that these forward-looking statements are subject to risks that may cause our actual results to differ materially from those indicated. Factors
- Read more current TGTX analysis and news
- View all earnings call transcripts